# Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

> **NCT05209997** · — · WITHDRAWN · sponsor: **Eurofarma Laboratorios S.A.**

## Conditions studied

- Overweight
- Obesity

## Interventions

- **OTHER:** Source document data collection

## Key facts

- **NCT ID:** NCT05209997
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn following a thorough evaluation of the current scientific landscape and ongoing advancements in the field. This decision was made to ensure that the research remains aligned with the highest standards of innova
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05209997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05209997, "Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05209997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*